CAS 706779-91-1
:Pimavanserin
Description:
Pimavanserin is an atypical antipsychotic primarily used in the treatment of Parkinson's disease psychosis. It is classified as a selective serotonin inverse agonist, specifically targeting the 5-HT2A receptor, which distinguishes it from traditional antipsychotics that often block dopamine receptors. This unique mechanism allows Pimavanserin to alleviate psychotic symptoms without exacerbating motor symptoms associated with Parkinson's disease. The compound is typically administered orally and has a favorable pharmacokinetic profile, with a relatively long half-life that supports once-daily dosing. Its chemical structure includes a complex arrangement of aromatic rings and heteroatoms, contributing to its specific receptor affinity and therapeutic effects. Pimavanserin is generally well-tolerated, with a side effect profile that is distinct from other antipsychotics, making it a valuable option for patients with Parkinson's-related psychosis. As with any medication, monitoring for potential side effects and interactions is essential during treatment.
Formula:C25H34FN3O2
InChI:InChI=1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30)
InChI key:InChIKey=RKEWSXXUOLRFBX-UHFFFAOYSA-N
SMILES:N(CC1=CC=C(F)C=C1)(C(NCC2=CC=C(OCC(C)C)C=C2)=O)C3CCN(C)CC3
Synonyms:- 1-(4-Fluorobenzyl)-1-(1-Methylpiperidin-4-Yl)-3-[4-(2-Methylpropoxy)Benzyl]Urea
- 1-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea
- 1-[(4-Fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
- N-(4-Fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-[[4-(2-methylpropyloxy)phenyl]methyl]carbamide
- N-[(4-Fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N′-[[4-(2-methylpropoxy)phenyl]methyl]urea
- Nuplazid
- Urea, N-[(4-fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N′-[[4-(2-methylpropoxy)phenyl]methyl]-
- Pimavanserin
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 15 products.
Pimavanserin Hemitartrate
CAS:Formula:C25H34FN3O2·5C4H6O6Color and Shape:White To Off-White SolidMolecular weight:427.56 0.5*150.09Pimavanserin-d4
CAS:Formula:C25H30D4FN3O2Color and Shape:White To Off-White SolidMolecular weight:431.59Pimavanserin
CAS:Pimavanserin is a potent 5-HT2A inverse agonist, used to treat Parkinson's psychosis.Formula:C25H34FN3O2Purity:97.84% - 99.69%Color and Shape:Pale Yellow To Pale Orange SolidMolecular weight:427.55Pimavanserin
CAS:Inverse agonist of 5-HT2A serotonin receptor; anti-psychotic
Formula:C25H34FN3O2Purity:Min. 95%Color and Shape:White PowderMolecular weight:427.55 g/molPimavanserin
CAS:Controlled ProductApplications Drug used in the treatment of Parkinson’s disease and psychosis.
References Snigdha, S., et al.: J. Pharmacol. Exper. Ther., 332, 622 (2010), Meltzer, H., et al.: Neuropsychopharmacol., 35, 881 (2010),Formula:C25H34FN3O2Color and Shape:NeatMolecular weight:427.554-[(E)-(1-methyl-4-piperidyl)iminomethyl]phenol
CAS:Controlled ProductApplications 4-[(E)-(1-methyl-4-piperidyl)iminomethyl]phenol is an impurity of Pimavanserin (P441800), which is a drug used in the treatment of Parkinson’s disease and psychosis.
References Snigdha, S., et al.: J. Pharmacol. Exper. Ther., 332, 622 (2010), Meltzer, H., et al.: Neuropsychopharmacol., 35, 881 (2010)Formula:C13H18N2OColor and Shape:NeatMolecular weight:218.2951,1-bis[(4-Fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]urea
CAS:Controlled ProductFormula:C26H28F2N2O2Color and Shape:NeatMolecular weight:438.511-Benzyl-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)urea
CAS:Controlled ProductFormula:C25H35N3O2Color and Shape:NeatMolecular weight:409.564N,N-bis[(4-fluorophenyl)methyl]piperidin-4-amine
CAS:Controlled ProductFormula:C19H22F2N2Color and Shape:NeatMolecular weight:316.388Pimavanserin-d9
CAS:Controlled ProductFormula:C25D9H25FN3O2Color and Shape:NeatMolecular weight:436.61







